Dual inhibition of independent cell survival pathways as a new approach for targeting leukemic stem cells

  • Guthridge, Mark Andrew (Primary Chief Investigator (PCI))
  • Ekert, Paul G. (Chief Investigator (CI))
  • Wei, Andrew (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/12 → 31/12/14

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$543,675.00
  • National Health and Medical Research Council (NHMRC) (Australia): A$120,000.00